Bronchogenic Carcinoma in Chronic Obstructive Pulmonary Disease
Anne L. Davis
Abstract
Anne L. Davis
Abstract
Among 835 subjects followed up prospectively for chronic obstructive pulmonary disease during the past 19 years, lung cancer has developed in 42 and has been histologically confirmed in 30. Follow-up averages 4.3 years or a total of 3,629 man-years. The incidence of 11.6/1,000 man-years is four to five times that reported in other series of smokers or in subjects with bronchitis. Underlying lung damage may be an important contributing factor. The symptoms of chronic obstructive pulmonary disease and the presence of minor roentgenographic abnormalities tend to conceal the evidence of cancer that is potentially curable. ( JAMA 235:621-622, 1976)
OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Among 835 subjects followed up prospectively for chronic obstructive pulmonary disease during the past 19 years, lung cancer has developed in 42 and has been histologically confirmed in 30. Follow-up averages 4.3 years or a total of 3,629 man-years. The incidence of 11.6/1,000 man-years is four to five times that reported in other series of smokers or in subjects with bronchitis. Underlying lung damage may be an important contributing factor. The symptoms of chronic obstructive pulmonary disease and the presence of minor roentgenographic abnormalities tend to conceal the evidence of cancer that is potentially curable. ( JAMA 235:621-622, 1976)
Key concepts: Medicine, Bronchogenic carcinoma, Pulmonary disease, Carcinoma, Intensive care medicine, Internal medicine